Susquehanna International Group’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Buy |
242,447
+175,832
| +264% | +$900K | ﹤0.01% | 2923 |
|
|
2025
Q1 | $91.3K | Buy |
66,615
+41,342
| +164% | +$56.6K | ﹤0.01% | 5883 |
|
|
2024
Q4 | $78.1K | Buy |
25,273
+8,965
| +55% | +$27.7K | ﹤0.01% | 5758 |
|
|
2024
Q3 | $126K | Buy |
16,308
+1,478
| +10% | +$11.4K | ﹤0.01% | 5034 |
|
|
2024
Q2 | $127K | Sell |
14,830
-28,062
| -65% | -$241K | ﹤0.01% | 5006 |
|
|
2024
Q1 | $341K | Buy |
42,892
+16,476
| +62% | +$131K | ﹤0.01% | 4019 |
|
|
2023
Q4 | $262K | Buy |
26,416
+1,578
| +6% | +$15.6K | ﹤0.01% | 4689 |
|
|
2023
Q3 | $280K | Buy |
24,838
+9,190
| +59% | +$103K | ﹤0.01% | 4120 |
|
|
2023
Q2 | $52K | Sell |
15,648
-12,446
| -44% | -$41.3K | ﹤0.01% | 5200 |
|
|
2023
Q1 | $111K | Buy |
+28,094
| New | +$111K | ﹤0.01% | 5203 |
|
|
2022
Q4 | – | Sell |
-13,480
| Closed | -$49K | – | 6739 |
|
|
2022
Q3 | $49K | Buy |
+13,480
| New | +$49K | ﹤0.01% | 5504 |
|
|
2022
Q2 | – | Sell |
-332,000
| Closed | -$2.52M | – | 6662 |
|
|
2022
Q1 | $2.52M | Buy |
332,000
+215,120
| +184% | +$1.63M | ﹤0.01% | 1778 |
|
|
2021
Q4 | $1.28M | Buy |
+116,880
| New | +$1.28M | ﹤0.01% | 2516 |
|